107 related articles for article (PubMed ID: 7876544)
21. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
Seeler JS; Muchardt C; Podar M; Gaynor RB
Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
[TBL] [Abstract][Full Text] [Related]
22. Superinduction of IL-2 gene transcription in the presence of cycloheximide.
Zubiaga AM; Muñoz E; Huber BT
J Immunol; 1991 Jun; 146(11):3857-63. PubMed ID: 2033254
[TBL] [Abstract][Full Text] [Related]
23. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
24. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
Raouf A; Li V; Kola I; Watson DK; Seth A
Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
[TBL] [Abstract][Full Text] [Related]
25. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells.
Fafeur V; Tulasne D; Quéva C; Vercamer C; Dimster V; Mattot V; Stéhelin D; Desbiens X; Vandenbunder B
Cell Growth Differ; 1997 Jun; 8(6):655-65. PubMed ID: 9185999
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.
Lindemann RK; Braig M; Ballschmieter P; Guise TA; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):799-805. PubMed ID: 12632071
[TBL] [Abstract][Full Text] [Related]
27. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
28. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
29. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
30. Importance of ets1 proto-oncogene for breast cancer progression.
Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
[TBL] [Abstract][Full Text] [Related]
31. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
Beiqing L; Chen M; Whisler RL
J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
[TBL] [Abstract][Full Text] [Related]
32. Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression.
Nakazawa Y; Suzuki M; Manabe N; Yamada T; Kihara-Negishi F; Sakurai T; Tenen DG; Iwama A; Mochizuki M; Oikawa T
Oncogene; 2007 May; 26(24):3541-50. PubMed ID: 17213822
[TBL] [Abstract][Full Text] [Related]
33. Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells.
Ballschmieter P; Braig M; Lindemann RK; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):849-53. PubMed ID: 12632078
[TBL] [Abstract][Full Text] [Related]
34. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
Heckford SE; Gelmann EP; Matis LA
Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
[TBL] [Abstract][Full Text] [Related]
35. Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression.
Williams TM; Eisenberg L; Burlein JE; Norris CA; Pancer S; Yao D; Burger S; Kamoun M; Kant JA
J Immunol; 1988 Jul; 141(2):662-6. PubMed ID: 2838551
[TBL] [Abstract][Full Text] [Related]
36. Regulation of human T cell receptor beta gene expression by Ets-1.
Wotton D; Prosser HM; Owen MJ
Leukemia; 1993 Aug; 7 Suppl 2():S55-60. PubMed ID: 8361234
[TBL] [Abstract][Full Text] [Related]
37. Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development.
Vandenbunder B; Queva C; Desbiens X; Wernert N; Stehelin D
Invasion Metastasis; 1994-1995; 14(1-6):198-209. PubMed ID: 7657513
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.
Bhat NK; Thompson CB; Lindsten T; June CH; Fujiwara S; Koizumi S; Fisher RJ; Papas TS
Proc Natl Acad Sci U S A; 1990 May; 87(10):3723-7. PubMed ID: 2187191
[TBL] [Abstract][Full Text] [Related]
39. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1.
Bosselut R; Duvall JF; Gégonne A; Bailly M; Hémar A; Brady J; Ghysdael J
EMBO J; 1990 Oct; 9(10):3137-44. PubMed ID: 2209540
[TBL] [Abstract][Full Text] [Related]
40. Cot kinase regulation of IL-2 production in Jurkat T cells.
Ballester A; Tobeña R; Lisbona C; Calvo V; Alemany S
J Immunol; 1997 Aug; 159(4):1613-8. PubMed ID: 9257820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
